A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer

NCT00557596 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma
Pancreas

Interventions

DRUG: AEG35156

Sponsor

Aegera Therapeutics